| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.014 | 0.6 |